Autor: |
Yuan J; Department of Neurology and Geriatrics, Kagoshima University Graduate School of Medical and Dental Sciences, Japan., Ando M, Higuchi I, Sakiyama Y, Matsuura E, Michizono K, Watanabe O, Nagano S, Inamori Y, Hashiguchi A, Higuchi Y, Yoshimura A, Takashima H |
Jazyk: |
angličtina |
Zdroj: |
Internal medicine (Tokyo, Japan) [Intern Med] 2014; Vol. 53 (14), pp. 1563-8. Date of Electronic Publication: 2014 Jul 15. |
DOI: |
10.2169/internalmedicine.53.8922 |
Abstrakt: |
Emery-Dreifuss muscular dystrophy (EDMD) is caused by mutations in the EMD gene on the X chromosome, which codes for emerin, an inner nuclear membrane protein. Monoclonal antibodies against the N-terminus of emerin protein are used to screen for emerin deficiency in clinical practice. However, these tests may not accurately reflect the disease in some cases. We herein describe the identification of a splice site mutation in the EMD gene in a Japanese patient who suffered from complete atrioventricular conduction block, mild muscle weakness and joint contracture, and a persistently elevated serum creatine kinase level. We used multiple antibodies to confirm the presence of a novel truncating mutation in emerin without the transmembrane region and C-terminus in the skeletal muscle. |
Databáze: |
MEDLINE |
Externí odkaz: |
|